Share Email Print
cover

Proceedings Paper

Effects of interstitial laser immunotherapy for the treatment of metastatic cancer
Author(s): Cody Bahavar; Jessica Goddard; Allie Sikes; Ellen Boarman; Robert E Nordquist; Tomas Hode; Hong Liu; Wei R. Chen
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Laser immunotherapy (LIT) uses laser irradiation and immunological stimulation to treat metastatic cancers. The current mode of operation of LIT is through dye-enhanced non-invasive irradiation. Although this treatment has given promising results, there are still a number of challenges with this method, such as limited light penetration for deep tumors and strong light absorption by highly pigmented skins. Interstitial laser immunotherapy (ILIT), using a cylindrical diffuser, is designed to overcome these limitations. In this study, rat tumors were treated by ILIT with an 805 nm laser and varying doses of glycated chitosan, an immunological stimulant. The goal was to observe the effects of differing doses of the stimulant on the survival of the tumor-bearing rats. The results suggested that the optimal dose of glycated chitosan is in the range of 0.1 to 0.3 ml per rat tumor.

Paper Details

Date Published: 22 February 2013
PDF: 7 pages
Proc. SPIE 8582, Biophotonics and Immune Responses VIII, 858207 (22 February 2013); doi: 10.1117/12.2006462
Show Author Affiliations
Cody Bahavar, Univ. of Central Oklahoma (United States)
Jessica Goddard, Univ. of Central Oklahoma (United States)
Allie Sikes, Univ. of Central Oklahoma (United States)
Ellen Boarman, Univ. of Central Oklahoma (United States)
Robert E Nordquist, ImmunoPhotonics, Inc. (United States)
Tomas Hode, ImmunoPhotonics, Inc. (United States)
Hong Liu, ImmunoPhotonics, Inc. (United States)
Wei R. Chen, Univ. of Central Oklahoma (United States)


Published in SPIE Proceedings Vol. 8582:
Biophotonics and Immune Responses VIII
Wei R. Chen, Editor(s)

© SPIE. Terms of Use
Back to Top